โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT06153420RECRUITINGIRB Ready

Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).

Sponsored by CinPhloro Pharma, LLC

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...
๐Ÿ“Š
1 of 450 participants interested
0% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with predominant diarrhea (IBS-D) in adult patients. The main questions it aims to answer are: * To evaluate the efficacy of CIN-103 on symptoms of IBS-D when given to patients with IBS-D compared to a placebo.

Who Can Participate

Inclusion Criteria

Are adult male and female subjects โ‰ฅ 18 years of age; 2. Have a body mass index between 18 and 45 kg/m2, inclusive at Screening; 3. Meet Rome IV Criteria for IBS-D by subject self-report of recurrent abdominal pain that is associated with โ‰ฅ 2 of the following over the last โ‰ฅ 6 months, with frequency of at least 1 day per week over the last 3 months (on average) before enrollment: 1. Related to defecation; 2. Associated with a change in frequency of stool; and/or 3. Associated with a change in form (appearance of stool). 4. Based on Investigator interview of subject's symptoms over the last 3 months, have โ‰ฅ 25% of bowel movements (BMs) with Bristol Stool Scale (BSS) Type 6 or 7 (loose or watery stools) and \< 25% of BMs with BSS Type 1 or 2 (lumpy or hard stools) per the Rome IV Criteria for IBS-D; 5. In the opinion of the Investigator, are on a stable diet for โ‰ฅ 4 weeks prior to Screening and are not planning to change lifestyle, exer

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

450 participants

โšง

Gender

ALL

๐Ÿข

Sponsor

CinPhloro Pharma, LLC

Study Locations

Choose your preferred location or select flexible during enrollment

Unknown

Dothan

Alabama

Location available
View Dothan location page
Unknown

Huntsville

Alabama

Location available
View Huntsville location page
Unknown

Phoenix

Arizona

Location available
View Phoenix location page
Unknown

Sun City

Arizona

Location available
View Sun City location page
Unknown

Little Rock

Arkansas

Location available
View Little Rock location page
Unknown

Garden Grove

California

Location available
View Garden Grove location page
Unknown

Lancaster

California

Location available
View Lancaster location page
Unknown

San Diego

California

Location available
View San Diego location page
Unknown

Cape Coral

Florida

Location available
View Cape Coral location page

๐Ÿ“ And 44 more locations available

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Looking for Irritable Bowel Syndrome Treatment in Dothan?

Join others in Alabama exploring innovative treatment options through clinical research

Irritable Bowel Syndrome Treatment Options in Dothan, Alabama

If you're searching for Irritable Bowel Syndrome treatment in Dothan, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Dothan, Huntsville, Phoenix and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Irritable Bowel Syndrome. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Alabama
Now Enrolling
Up to 450 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Irritable Bowel Syndrome?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Irritable Bowel Syndrome

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Irritable Bowel Syndrome Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06153420. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.